Table 1 Overall and by cancer demographics and clinic characteristics of 557 hospitalised patients with COVID-19.

From: Impact of active cancer on COVID-19 survival: a matched-analysis on 557 consecutive patients at an Academic Hospital in Lombardy, Italy

 

All patients

Non-cancer patients

Cancer patients

p-value

N

%

N

%

N

%

557

100.0

511

91.7

46

8.3

 

Gender

 Male

375

67.3

344

67.3

31

67.4

0.992

 Female

182

32.7

167

32.7

15

32.6

–

Age

 (mean CI 95%)

65 (64;68)

 

65 (64;66)

 

71 (67;74)

 

0.012

BMI

27

      

 (mean 95% CI)

27 (26.5;27.4)

–

27.1

26.6–27.6

25.2

23.7–26.8

0.026

 <30

384

68.9

346

76.2

38

90.5

0.034

 ≥30

112

20.1

108

23.8

4

9.5

 

 Missing

61

11

     

Diabetes

 No

419

75.2

385

75.5

34

73.9

0.812

 Yes

137

24.6

125

24.5

12

26.1

–

 Missing

1

0.2

–

–

–

–

–

Hypertension

 No

272

48.8

247

48.4

25

54.3

0.442

 Yes

284

51.0

263

51.6

21

45.7

–

 Missing

1

0.2

–

–

–

–

–

Dyslipidemia

 No

434

77.9

401

78.6

33

71.7

0.28

 Yes

122

21.9

109

21.4

13

28.3

–

 Missing

1

0.2

–

–

–

–

–

Smoking

 No/former

507

91

47.0

92.0

37

80.4

0.009

 Yes

50

9.0

41

8.0

9

19.6

–

CAD

 No

442

79.4

410

80.4

32

69.6

0.082

 Yes

114

20.5

100

19.6

14

30.4

–

 Missing

1

0.2

–

–

–

–

–

Lymphocytes

 <1000

282

50.6

251

49.1

31

67.4

0.018

 ≥1000

275

49.4

260

50.9

15

32.6

–

LDH

 <248

146

26.2

135

26.7

11

24.4

0.739

 ≥248

404

72.5

370

73.3

34

75.6

–

 Missing

7

1.3

–

–

–

–

–

IL-6

 No

352

63.2

325

82.9

27

87.1

0.802

 Yes

71

12.7

67

17.1

4

12.9

–

 Missing

134

24.1

–

–

–

–

–

PCT

 <0.5

411

73.8

381

74.7

30

65.2

0.16

 ≥0.5

145

26.0

129

25.3

16

34.8

–

 Missing

1

0.2

–

–

–

–

–

CRP

 <0.5

21

3.8

19

3.7

2

4.3

0.83

 ≥0.5

536

96.2

492

96.3

44

95.7

–

Ferritin

 <336.2

196

35.2

183

38.2

13

35.1

0.711

 ≥336.2

320

57.4

296

61.8

24

64.9

–

 Missing

41

7.4

–

–

–

–

–

NLR

 (mean 95% CI)

5.84

0.06;85

8.22

7.56;8.89

13.32

8.37;18.26

0.046

PaO2/FiO2

 (mean 95% CI)

304 (46;561)

 

291.6 (283.3;300)

 

283 (253.4, 312.5)

 

0.558

Ground glass opacities

 No

26

4.7

22

4.5

4

9.8

0.135

 Yes

504

90.5

467

95.5

37

90.2

 

 Missing

27

4.8

     

Pulmonary consolidations

 No

383

68.8

355

72.6

28

68.3

0.554

 Yes

147

26.4

134

27.4

13

31.7

 

 Missing

27

4.8

     

Pleural effusion

 No

462

82.9

434

88.8

28

68.3

<0.001

 Yes

68

12.3

55

11.2

13

31.7

 

 Missing

27

4.8

     

Pulmonary adenopathy

 No

375

67.3

345

70.6

30

73.2

0.723

 Yes

155

27.9

144

29.4

11

26.8

 

 Missing

27

4.8

     
  1. CAD coronary artery disease, BMI body mass index, CI confidence interval, LDH lactate dehydrogenase, IL-6 interleukin-6, PCT procalcitonin, NLR neutrophil–lymphocyte ratio.
  2. Statistically significant p < 0.05 values are in bold.
Back to article page